S. Ahuja

发表

Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial.

F. Montorsi, G. Broderick, G. Brock, 2004, The Journal of urology.

Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design.

C. Niederberger, F. Natanegara, A. Morgentaler, 2006, The journal of sexual medicine.

Efficacy of tadalafil in the treatment of erectile dysfunction in hypertensive men on concomitant thiazide diuretic therapy

R. Kloner, R. Sadovsky, S. Ahuja, 2005, International Journal of Impotence Research.

Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.

W. Shen, C. Beasley, S. Auerbach, 2005, Journal of andrology.

The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.

P. Knapp, A. Seftel, Steven K. Wilson, 2004, The Journal of urology.

A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction.

J. Denne, F. Govier, P. Kovalenko, 2003, Clinical therapeutics.

Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.

Edward D. Kim, I. Goldstein, W. Steers, 2007, The journal of sexual medicine.

Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials

A. Burnett, I. Sharlip, I. Eardley, 2005, BJU international.

The efficacy of tadalafil in clinical populations.

W. Shen, I. Eardley, M. O'Leary, 2005, The journal of sexual medicine.

875: High Prevalence of Significant Comorbid Conditions in Men with Erectile Dysfunction: Momentus Trial Demonstrates Efficacy and Safety of Tadalafil in this Group

Edward D. Kim, I. Goldstein, W. Steers, 2005 .

Semen and sperm reference ranges for men 45 years of age and older.

Jean S. Whitaker, J. Denne, W. Cordell, 2006, Journal of andrology.

Through the eyes of women: the partners' perspective on tadalafil.

F. Natanegara, G. Brock, S. Althof, 2006, Urology.

Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.

L. Valiquette, G. Broderick, D. Hatzichristou, 2006, Journal of Sexual Medicine.

Rationale for a non-inferiority clinical trial design focused on subpopulations

P. Kulkarni, D. Muram, E. Meadows, 2004, Current medical research and opinion.

Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction.

R. Rosen, F. Giuliano, R. Shabsigh, 2006, Urology.